CONTROL joint meeting
May 23, 2022, 13.00-17.00
Hindsgavl Slot
Hindsgavl Allé 7, 5500 Middelfart
| 13.00-14.00 | Lunch | |
| 14.00-14.15 | Introduction | by Kjeld Schmiegelow |
|
14.15-14.50 Treatment and response |
||
| 14.15-14.25 | Experimental anti-cancer treatment | by Karsten Nysom |
| 14.25-14.35 | Imaging and bioinformatics | by Claes Ladefoged |
|
14.50-15.25 Genes and proteins |
||
| 14.50-15.00 | Low cost cancer predisposition analysis of large cohorts - DoBSeq method developed by using STAGING data | by Ulrik Stoltze |
| 15.00-15.10 | Proteomics of the cerebrospinal fluid | by Christian Mirian |
| 15.25-15.40 | Break | |
| 15.40-16.10 | Keynote speaker | geneticist and pediatric oncologist Michael Walsh |
|
16.10-16.45 Impairment and care |
||
| 16.10-16.20 | Neurocognitive impairment in long-term childhood brain tumor survivors | by Anne Sophie Lind Fischer |
| 16.20-16.30 | UNITED – A field study of families’ needs during childhood oncology treatment | by Minna Devantier |
| 16.45-17.00 | Concluding remarks | by Henrik Hasle |
